Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity.

Ivim takes a comprehensive approach to obesity care and its customized patient-centric plans are carefully overseen by ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival Eli Lilly discounted some of its Zepbound injections last week. The Danish ...

Teladoc Health has announced a pharmacy integration agreement with Eli Lilly's Gifthealth to facilitate access to FDA-approved Zepbound® (tirzepatide) for members of its Comprehensive Weight Care ...

Teladoc Health partners with Eli Lilly’s LillyDirect to streamline Zepbound access for weight ... patients to get a prescription for weight loss through a telehealth provider, marking an ...